Fri, 18 Jan 2019 18:59:42: ALS researchers at Harvard uncover new biomarker and drug target

Fri, 18 Jan 2019 13:25:25: Celgene strikes Obsidian deal to boost CAR-T options 

Fri, 18 Jan 2019 12:29:09: Former Insmed CMO Streck resurfaces at Alder

Fri, 18 Jan 2019 07:57:53: Novartis allies with Oxford academics for big data R&D drive

Thu, 17 Jan 2019 19:11:20: Chutes & Ladders—Exoduses continue at AstraZeneca

Thu, 17 Jan 2019 16:57:03: Apple, J&J to put the Apple Watch’s ECG through large-scale clinical testing

Thu, 17 Jan 2019 14:20:50: Gilead’s clinical research VP moves to U.S.-China NASH startup Terns Pharma

Thu, 17 Jan 2019 13:53:24: Lipocine talks up interim data from small NASH study

Thu, 17 Jan 2019 13:04:59: It's a case of déjà vu as Alzheon pulls IPO again

Thu, 17 Jan 2019 11:36:16: Could a safer version of an old blood pressure drug be repurposed in multiple sclerosis?

Thu, 17 Jan 2019 11:22:18: Aptinyx fails phase 2 pain test, sparking stock crash

Wed, 16 Jan 2019 13:59:39: Five Prime cuts 41 jobs, narrows focus to clinical-stage drugs

Wed, 16 Jan 2019 13:32:25: Life Biosciences raises $50M as longevity race heats up

Wed, 16 Jan 2019 11:08:58: Anti-aging startup Juvenescence bags $46M for pipeline push

Wed, 16 Jan 2019 09:41:31: NIH’s stem cell-based AMD therapy set for first human trial

Tue, 15 Jan 2019 19:41:34: FDA planning new guidance, hires in cell and gene therapies for 2019

Tue, 15 Jan 2019 14:37:01: Seres elevates CFO Eric Shaff to CEO post as it advances immunology therapies

Tue, 15 Jan 2019 13:52:27: As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations

Tue, 15 Jan 2019 13:34:04: Attendees fed up with venue, high prices call to move JPM out of San Francisco

Tue, 15 Jan 2019 13:01:44: Aimmune says shutdown blocks peanut allergy drug review

Tue, 15 Jan 2019 12:25:00: Roche R&D executive begins a new voyage with biotech move

Tue, 15 Jan 2019 09:53:30: Another AstraZeneca executive hits the exit, joins alumnus at Immunocore

Tue, 15 Jan 2019 09:15:53: Insmed CMO out the door, headed for 'West Coast'

Mon, 14 Jan 2019 14:26:01: Sean Bohen to leave AstraZeneca as exodus continues

Mon, 14 Jan 2019 13:54:47: Verona tanks after COPD drug misses phase 2 endpoint